Literature DB >> 21457616

Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London.

Juliana Puppi1, Stephen C Strom, Robin D Hughes, Sanjay Bansal, Jose V Castell, Ibrahim Dagher, Ewa C S Ellis, Greg Nowak, Bo-Goran Ericzon, Ira J Fox, M José Gómez-Lechón, Chandan Guha, Sanjeev Gupta, Ragai R Mitry, Kazuo Ohashi, Michael Ott, Lola M Reid, Jayanta Roy-Chowdhury, Etienne Sokal, Anne Weber, Anil Dhawan.   

Abstract

On September 6 and 7, 2009 a meeting was held in London to identify and discuss what are perceived to be current roadblocks to effective hepatocyte transplantation as it is currently practiced in the clinics and, where possible, to offer suggestions to overcome the blocks and improve the outcomes for this cellular therapy. Present were representatives of most of the active clinical hepatocyte transplant programs along with other scientists who have contributed substantial basic research to this field. Over the 2-day sessions based on the experience of the participants, numerous roadblocks or challenges were identified, including the source of cells for the transplants and problems with tracking cells following transplantation. Much of the discussion was focused on methods to improve engraftment and proliferation of donor cells posttransplantation. The group concluded that, for now, parenchymal hepatocytes isolated from donor livers remain the best cell source for transplantation. It was reported that investigations with other cell sources, including stem cells, were at the preclinical and early clinical stages. Numerous methods to modulate the immune reaction and vascular changes that accompany hepatocyte transplantation were proposed. It was agreed that, to obtain sufficient levels of repopulation of liver with donor cells in patients with metabolic liver disease, some form of liver preconditioning would likely be required to enhance the engraftment and/or proliferation of donor cells. It was reported that clinical protocols for preconditioning by hepatic irradiation, portal vein embolization, and surgical resection had been developed and that clinical studies using these protocols would be initiated in the near future. Participants concluded that sharing information between the groups, including standard information concerning the quality and function of the transplanted cells prior to transplantation, clinical information on outcomes, and standard preconditioning protocols, would help move the field forward and was encouraged.

Entities:  

Mesh:

Year:  2012        PMID: 21457616     DOI: 10.3727/096368911X566208

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  72 in total

Review 1.  Liver-Regenerative Transplantation: Regrow and Reset.

Authors:  A Collin de l'Hortet; K Takeishi; J Guzman-Lepe; K Handa; K Matsubara; K Fukumitsu; K Dorko; S C Presnell; H Yagi; A Soto-Gutierrez
Journal:  Am J Transplant       Date:  2016-02-18       Impact factor: 8.086

Review 2.  Human Liver Progenitor Cells for Liver Repair.

Authors:  Catherine A Lombard; Julie Prigent; Etienne M Sokal
Journal:  Cell Med       Date:  2013-04-29

3.  Improvement of Infusion Process in Cell Transplantation: Effect of Shear Stress on Hepatocyte Viability Under Horizontal and Vertical Syringe Orientation.

Authors:  Sandi Sufiandi; Hiromichi Obara; Shin Enosawa; Huai-Che Hsu; Naoto Matsuno; Hiroshi Mizunuma
Journal:  Cell Med       Date:  2014-12-12

4.  New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases.

Authors:  Jennifer R Ferrer; Attasit Chokechanachaisakul; Jason A Wertheim
Journal:  Curr Transplant Rep       Date:  2015-06-01

Review 5.  Hepatocyte Transplantation: Quo Vadis?

Authors:  Mark Barahman; Patrik Asp; Namita Roy-Chowdhury; Milan Kinkhabwala; Jayanta Roy-Chowdhury; Rafi Kabarriti; Chandan Guha
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-29       Impact factor: 7.038

6.  Functional ultrasound imaging for assessment of extracellular matrix scaffolds used for liver organoid formation.

Authors:  Ryan C Gessner; Ariel D Hanson; Steven Feingold; Avery T Cashion; Ana Corcimaru; Bryant T Wu; Christopher R Mullins; Stephen R Aylward; Lola M Reid; Paul A Dayton
Journal:  Biomaterials       Date:  2013-09-04       Impact factor: 12.479

7.  Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models.

Authors:  Clara T Nicolas; Raymond D Hickey; Kari L Allen; Zeji Du; Rebekah M Guthman; Robert A Kaiser; Bruce Amiot; Aditya Bansal; Mukesh K Pandey; Lukkana Suksanpaisan; Timothy R DeGrado; Scott L Nyberg; Joseph B Lillegard
Journal:  Surgery       Date:  2018-06-06       Impact factor: 3.982

8.  SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS.

Authors:  Maria-Louisa Izamis; Candice Calhoun; Basak E Uygun; Maria Angela Guzzardi; Gavrielle Price; Martha Luitje; Nima Saeidi; Martin L Yarmush; Korkut Uygun
Journal:  Cell Med       Date:  2013

Review 9.  Emerging advancements in liver regeneration and organogenesis as tools for liver replacement.

Authors:  Stacey S Huppert; Kathleen M Campbell
Journal:  Curr Opin Organ Transplant       Date:  2016-12       Impact factor: 2.640

Review 10.  Biofabrication of Autologous Human Hepatocytes for Transplantation: How Do We Get There?

Authors:  Nandini Agarwal; Branimir Popovic; Nicole J Martucci; Nicolas A Fraunhoffer; Alejandro Soto-Gutierrez
Journal:  Gene Expr       Date:  2018-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.